Ultragenyx Pharmaceutical, Inc. (RARE)
22.87
+0.42
(+1.87%)
USD |
NASDAQ |
Apr 06, 16:00
22.86
0.00 (0.00%)
After-Hours: 20:00
Ultragenyx Pharmaceutical SG&A Expense (TTM) : 350.06M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 448.72M |
| BioMarin Pharmaceutical, Inc. | 1.153B |
| Catalyst Pharmaceuticals, Inc. | 171.18M |
| Regeneron Pharmaceuticals, Inc. | 2.70B |
| Xencor, Inc. | 63.64M |